CryoCell International Inc (CCEL)vsFresenius Medical Care Corporation (FMS)
CCEL
CryoCell International Inc
$3.42
-3.36%
HEALTHCARE · Cap: $27.55M
FMS
Fresenius Medical Care Corporation
$24.02
+0.46%
HEALTHCARE · Cap: $12.64B
Smart Verdict
WallStSmart Research — data-driven comparison
Fresenius Medical Care Corporation generates 61786% more annual revenue ($19.36B vs $31.28M). FMS leads profitability with a 4.9% profit margin vs -8.5%. FMS appears more attractively valued with a PEG of 0.84. FMS earns a higher WallStSmart Score of 50/100 (C-).
CCEL
Hold39
out of 100
Grade: F
FMS
Buy50
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+34.8%
Fair Value
$5.12
Current Price
$3.42
$1.70 discount
Margin of Safety
+68.8%
Fair Value
$77.05
Current Price
$24.02
$53.03 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 129 in profit
Conservative balance sheet, low leverage
Reasonable price relative to book value
Growing faster than its price suggests
Attractively priced relative to earnings
Areas to Watch
Smaller company, higher risk/reward
Revenue declined 3.6%
Earnings declined 80.5%
Distress zone — elevated risk
Grey zone — moderate risk
ROE of 7.1% — below average capital efficiency
4.9% margin — thin
Revenue declined 5.5%
Comparative Analysis Report
WallStSmart ResearchBull Case : CCEL
The strongest argument for CCEL centers on Return on Equity, Debt/Equity. PEG of 1.34 suggests the stock is reasonably priced for its growth.
Bull Case : FMS
The strongest argument for FMS centers on Price/Book, PEG Ratio, P/E Ratio. PEG of 0.84 suggests the stock is reasonably priced for its growth.
Bear Case : CCEL
The primary concerns for CCEL are Market Cap, Revenue Growth, EPS Growth.
Bear Case : FMS
The primary concerns for FMS are Altman Z-Score, Return on Equity, Profit Margin. Thin 4.9% margins leave little buffer for downturns.
Key Dynamics to Monitor
CCEL profiles as a turnaround stock while FMS is a value play — different risk/reward profiles.
FMS carries more volatility with a beta of 0.82 — expect wider price swings.
CCEL is growing revenue faster at -3.6% — sustainability is the question.
FMS generates stronger free cash flow (37M), providing more financial flexibility.
Bottom Line
FMS scores higher overall (50/100 vs 39/100). CCEL offers better value entry with a 34.8% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
CryoCell International Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Cryo-Cell International, Inc. is dedicated to cell processing and cryogenic cell storage with a focus on collecting and preserving umbilical cord blood stem cells for family use. The company is headquartered in Oldsmar, Florida.
Fresenius Medical Care Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?